查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600165

非侵入性产前检测市场：按产品、方法、测试类型、应用和最终用户 - 2025-2030 年全球预测

Non-invasive Prenatal Testing Market by Product (Consumables, Instruments), Method (Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Fetal Cells in Maternal Blood Tests), Test Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年非侵入性产前检测市值为74亿美元，预计2024年将达78亿美元，复合年增长率为5.47%，到2030年将达到107.5亿美元。

非侵入性产前检测 (NIPT) 包括最先进的产前筛检方法，利用孕妇血液中循环的游离胎儿 DNA 来检测唐氏症、爱德华兹症候群和帕陶氏症等疾病，评估您患有某有些遗传疾病的风险。 NIPT 的需求在于，与羊膜穿刺术等侵入性方法相比，它能够以最小的风险提供高精度。 NIPT的应用范围不仅限于染色体异常筛检，还可能扩展到单染色体异常和产前性别测定。典型的最终用户包括医院、诊断实验室和产科专科诊所。市场成长的主要驱动力是母亲年龄的增加、基因检测意识的提高以及基因组学技术的进步。

主要市场统计
基准年[2023] 74亿美元
预测年份 [2024] 78亿美元
预测年份 [2030] 107.5亿美元
复合年增长率（%） 5.47%

潜在的成长机会存在于新兴市场，这些市场医疗保健服务的可用性和意识的提高正在增加 NIPT 的采用。此外，公司和医疗保健提供者之间的伙伴关係有可能扩大 NIPT 的覆盖范围。主要建议包括专注于降低成本以提高可及性，特别是在发展中地区，以及开发全面的测试，以更快、更广泛地了解产前健康状况。然而，诸如高成本、道德考虑以及需要熟练人员进行测试和提供咨询等挑战正在阻碍市场扩张。道德和解释问题方面的权衡以及报销问题也构成了主要障碍。

提高测试特异性和灵敏度、将人工智慧应用于资料分析以及扩展测试参数以包含更多疾病状态等领域的创新和研究将是有益的。了解市场的高度竞争性质至关重要，许多公司都专注于技术进步和策略联盟。专注于研发和强有力的行销策略的公司也许能够透过利用市场动态和解决产前护理方面未满足的需求来实现持续成长。

市场动态：快速发展的非侵入性产前检测市场的关键市场洞察

非侵入性产前检测市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 随着母亲年龄的增加，染色体异常的发生率增加
    • 相对于侵入性方法，人们越来越偏好无创技术
    • 提高孕妇对 NIPT 的好处和可用性的认识
  • 市场限制因素
    • 医疗基础设施不足，农村和人口稀少地区获得先进医疗技术的机会有限。
  • 市场机会
    • 透过提供全面的测试前和测试后咨询服务来改善患者体验和接受度
    • 安全可靠的家用检测套组的开发和核准
  • 市场挑战
    • 测试结果的可靠性，尤其是肥胖女性

波特五力：驾驭无创产前检测市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对非侵入性产前检测市场的影响

外部宏观环境因素在塑造非侵入性产前检测市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解非侵入性产前检测市场的竞争格局

对非侵入性产前检测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵非侵入性产前检测市场供应商的绩效评估

FPNV定位矩阵是评估非侵入性产前检测市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了无创产前检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对无创产前检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着母亲年龄的增长，染色体异常的发生率增加
      • 无创技术
      • 提高孕妇对 NIPT 的好处和可用性的认识
    • 抑制因素
      • 农村和发展中地区的医疗基础设施不足，获得先进医疗技术的机会有限。
    • 机会
      • 提供全面的测试前和测试后咨询服务，以增强患者的体验和理解
      • 安全可靠的家庭检测套组的开发和核准
    • 任务
      • 测试结果的可靠性，特别是对于肥胖女性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 非侵入性产前检测市场：副产品

  • 消耗品
    • 检测套件和试剂
    • 一次性的
  • 装置
    • 微阵列
    • 次世代定序系统
    • 聚合酵素链锁反应装置
    • 超音波设备

第七章 非侵入性产前检测市场：依方法分类

  • 生化筛检试验
  • 母体血浆检测中的游离 DNA
  • 母体血液检查中的胎儿细胞
  • 超音波检测

第八章按测试类型分類的非侵入性产前检测市场

  • 和谐测试
  • MaterniT21 Plus 测试
  • 全景测试
  • 检验测试

第九章 非侵入性产前检测市场：依应用分类

  • 唐氏症（21 三体）
  • 爱德华兹氏症候群（18 三体）
  • 微缺失症候群
  • 巴陶氏症（13 三体）
  • 性染色体异常

第10章无创产前检测市场：依最终用户分类

  • 诊断实验室
  • 医院
  • 调查机构
  • 专科诊所

第十一章 美洲非侵入性产前检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太无创产前检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲、中东和非洲无创产前检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Natera 推出基于 cfDNA 的胎儿 RhD 检测，以对抗 RhIg 缺乏症，确保 100% 的敏感性、99% 的特异性和优化的患者照护。
    • BillionToOne 推出 BabyPeek，一种非侵入性产前基因测试，扩大市场范围和消费者选择，同时提供对胎儿特征的有趣见解。
    • Natera, Inc. 收购 Invitae 资产以加强非侵入性产前检测产品
  • 战略分析和建议
    • 纳特拉有限公司

公司名单

  • Agilent Technologies, Inc.
  • Berry Genomics Co. Ltd.
  • BGI Group
  • BillionToOne, Inc.
  • Biora Therapeutics, Inc.
  • BioReference Laboratories, Inc.
  • Centogene NV
  • Eurofins LifeCodexx AG by Eurofins Scientific
  • F.Hoffmann-La Roche Ltd.
  • GE HealthCare Technologies Inc.
  • Igenomix
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Lilac Insights Pvt. Ltd.
  • MedGenome Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Ravgen Inc.
  • Sonic Healthcare Limited
  • Thermo Fisher Scientific Inc.
  • Yourgene Health by Novacyt UK Holdings Limited
Product Code: MRR-036C5CF3B521

The Non-invasive Prenatal Testing Market was valued at USD 7.40 billion in 2023, expected to reach USD 7.80 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 10.75 billion by 2030.

Non-invasive Prenatal Testing (NIPT) encompasses a cutting-edge approach in prenatal screening, leveraging cell-free fetal DNA circulating in a pregnant woman's blood to assess the risk of certain genetic conditions, such as Down syndrome, Edwards syndrome, and Patau syndrome. The necessity of NIPT lies in its ability to offer high accuracy with minimal risk compared to invasive methods like amniocentesis. Its applications extend beyond screening for chromosomal abnormalities to potentially include monogenic disorders and prenatal sex determination. Key end-users include hospitals, diagnostic labs, and specialized maternity clinics. The market growth is primarily driven by increasing maternal age, growing awareness about genetic testing, and technological advancements in genomics.

KEY MARKET STATISTICS
Base Year [2023] USD 7.40 billion
Estimated Year [2024] USD 7.80 billion
Forecast Year [2030] USD 10.75 billion
CAGR (%) 5.47%

Potential growth opportunities are found in emerging markets, where the adoption of NIPT is rising due to the increasing availability of healthcare services and awareness. Moreover, partnerships between companies and healthcare providers can expand the reach of NIPT. Key recommendations include focusing on reducing costs to enhance accessibility, especially in developing regions, and developing comprehensive tests that provide faster and broader insights into prenatal health. However, challenges such as high costs, ethical considerations, and the need for skilled personnel for test administration and counseling restrain the market expansion. Trade-offs related to ethical and interpretational challenges, along with reimbursement issues, also pose significant hurdles.

Innovation and research in areas like improving the specificity and sensitivity of tests, applying artificial intelligence for data analysis, and expanding test parameters to include more conditions could be beneficial. Understanding the nature of the market, which is increasingly competitive with numerous players focusing on technological advancements and strategic collaborations, is paramount. Companies that emphasize research and development, coupled with robust marketing strategies, have the potential to capitalize on the market dynamics and cater to the unmet needs in prenatal care, positioning themselves for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Non-invasive Prenatal Testing Market

The Non-invasive Prenatal Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of chromosomal abnormalities with increasing maternal age
    • Growing preference for non-invasive techniques over invasive methods
    • Increased awareness among pregnant women about the benefits and availability of NIPT
  • Market Restraints
    • Inadequate healthcare infrastructure and limited access to advanced medical technologies in rural or underdeveloped areas
  • Market Opportunities
    • Providing comprehensive pre-test and post-test counseling services to enhance patient experience and uptake
    • Development and approval of secure and reliable home-testing kits
  • Market Challenges
    • Reliability of test results, especially in obese women

Porter's Five Forces: A Strategic Tool for Navigating the Non-invasive Prenatal Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Non-invasive Prenatal Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Non-invasive Prenatal Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Non-invasive Prenatal Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Non-invasive Prenatal Testing Market

A detailed market share analysis in the Non-invasive Prenatal Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Non-invasive Prenatal Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Non-invasive Prenatal Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Non-invasive Prenatal Testing Market

A strategic analysis of the Non-invasive Prenatal Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-invasive Prenatal Testing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Berry Genomics Co. Ltd., BGI Group, BillionToOne, Inc., Biora Therapeutics, Inc., BioReference Laboratories, Inc., Centogene N.V., Eurofins LifeCodexx AG by Eurofins Scientific, F.Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., Igenomix, Illumina, Inc., Laboratory Corporation of America Holdings, Lilac Insights Pvt. Ltd., MedGenome Inc., Myriad Genetics, Inc., Natera, Inc., PerkinElmer Inc., Quest Diagnostics Incorporated, Ravgen Inc., Sonic Healthcare Limited, Thermo Fisher Scientific Inc., and Yourgene Health by Novacyt UK Holdings Limited.

Market Segmentation & Coverage

This research report categorizes the Non-invasive Prenatal Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Assay Kits & Reagents and Disposables. The Instruments is further studied across Microarrays, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, and Ultrasound Devices.
  • Based on Method, market is studied across Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Fetal Cells in Maternal Blood Tests, and Ultrasound Detection.
  • Based on Test Type, market is studied across Harmony Test, MaterniT21 Plus Test, Panorama Test, and Verifi Test.
  • Based on Application, market is studied across Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), Microdeletion Syndrome, Patau Syndrome (Trisomy 13), and Sex Chromosome Disorders.
  • Based on End User, market is studied across Diagnostic Laboratories, Hospitals, Research Institutes, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of chromosomal abnormalities with increasing maternal age
      • 5.1.1.2. Growing preference for non-invasive techniques over invasive methods
      • 5.1.1.3. Increased awareness among pregnant women about the benefits and availability of NIPT
    • 5.1.2. Restraints
      • 5.1.2.1. Inadequate healthcare infrastructure and limited access to advanced medical technologies in rural or underdeveloped areas
    • 5.1.3. Opportunities
      • 5.1.3.1. Providing comprehensive pre-test and post-test counseling services to enhance patient experience and uptake
      • 5.1.3.2. Development and approval of secure and reliable home-testing kits
    • 5.1.4. Challenges
      • 5.1.4.1. Reliability of test results, especially in obese women
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Non-invasive Prenatal Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Assay Kits & Reagents
    • 6.2.2. Disposables
  • 6.3. Instruments
    • 6.3.1. Microarrays
    • 6.3.2. Next-Generation Sequencing Systems
    • 6.3.3. Polymerase Chain Reaction Instruments
    • 6.3.4. Ultrasound Devices

7. Non-invasive Prenatal Testing Market, by Method

  • 7.1. Introduction
  • 7.2. Biochemical Screening Tests
  • 7.3. Cell-free DNA in Maternal Plasma Tests
  • 7.4. Fetal Cells in Maternal Blood Tests
  • 7.5. Ultrasound Detection

8. Non-invasive Prenatal Testing Market, by Test Type

  • 8.1. Introduction
  • 8.2. Harmony Test
  • 8.3. MaterniT21 Plus Test
  • 8.4. Panorama Test
  • 8.5. Verifi Test

9. Non-invasive Prenatal Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Down Syndrome (Trisomy 21)
  • 9.3. Edwards Syndrome (Trisomy 18)
  • 9.4. Microdeletion Syndrome
  • 9.5. Patau Syndrome (Trisomy 13)
  • 9.6. Sex Chromosome Disorders

10. Non-invasive Prenatal Testing Market, by End User

  • 10.1. Introduction
  • 10.2. Diagnostic Laboratories
  • 10.3. Hospitals
  • 10.4. Research Institutes
  • 10.5. Specialty Clinics

11. Americas Non-invasive Prenatal Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Non-invasive Prenatal Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Non-invasive Prenatal Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Natera launches cfDNA-based fetal RhD test to combat RhIg shortage, ensuring 100% sensitivity, 99% specificity, and optimized patient care
    • 14.3.2. BillionToOne launches BabyPeek, a non-invasive prenatal genetic test , expanding market reach and consumer choices while offering fun insights into unborn baby traits
    • 14.3.3. Natera, Inc. acquires Invitae assets to enhance non-invasive prenatal testing offerings
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Natera, Inc.

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Berry Genomics Co. Ltd.
  • 3. BGI Group
  • 4. BillionToOne, Inc.
  • 5. Biora Therapeutics, Inc.
  • 6. BioReference Laboratories, Inc.
  • 7. Centogene N.V.
  • 8. Eurofins LifeCodexx AG by Eurofins Scientific
  • 9. F.Hoffmann-La Roche Ltd.
  • 10. GE HealthCare Technologies Inc.
  • 11. Igenomix
  • 12. Illumina, Inc.
  • 13. Laboratory Corporation of America Holdings
  • 14. Lilac Insights Pvt. Ltd.
  • 15. MedGenome Inc.
  • 16. Myriad Genetics, Inc.
  • 17. Natera, Inc.
  • 18. PerkinElmer Inc.
  • 19. Quest Diagnostics Incorporated
  • 20. Ravgen Inc.
  • 21. Sonic Healthcare Limited
  • 22. Thermo Fisher Scientific Inc.
  • 23. Yourgene Health by Novacyt UK Holdings Limited

LIST OF FIGURES

  • FIGURE 1. NON-INVASIVE PRENATAL TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. NON-INVASIVE PRENATAL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NON-INVASIVE PRENATAL TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ASSAY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY FETAL CELLS IN MATERNAL BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HARMONY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MATERNIT21 PLUS TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PANORAMA TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY VERIFI TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DOWN SYNDROME (TRISOMY 21), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY EDWARDS SYNDROME (TRISOMY 18), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PATAU SYNDROME (TRISOMY 13), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SEX CHROMOSOME DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET S